Strados Labs is at the forefront of respiratory health innovation with its FDA-cleared RESP® Biosensor, a wearable stethoscope designed to monitor lung sounds and symptoms such as coughing and wheezing continuously. This state-of-the-art device adheres to the patient's chest, collecting real-time data that is then transferred via Bluetooth to a mobile app. This allows both patients and healthcare providers to access valuable insights into lung health from the comfort of home, thereby enhancing patient care and supporting clinical research.

Founded with a mission to improve respiratory monitoring, Strados Labs has successfully captured over 600,000 validated cough sounds and 19 million breaths across various patient demographics globally. The technology not only offers objective measurements for conditions like asthma and COPD but also emphasizes privacy through advanced encryption. With operations in cities like Philadelphia and Atlanta, Strados Labs exemplifies a commitment to making every breath count while ensuring that patients receive accurate assessments of their lung health in real-world scenarios.